Blood Biomarkers for Alzheimer's Disease in Down Syndrome.

Montoliu-Gaya, Laia; Strydom, Andre; Blennow, Kaj; Zetterberg, Henrik; Ashton, Nicholas James

Montoliu-Gaya, Laia; Strydom, Andre; Blennow, Kaj; Zetterberg, Henrik; Ashton, Nicholas James.

Afiliación

Montoliu-Gaya L; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 41 Mölndal, Sweden.
Strydom A; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London WC2R 2LS, UK.
Blennow K; South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK.
Zetterberg H; London Down Syndrome Consortium (LonDowns), London, UK.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 41 Mölndal, Sweden.

J Clin Med ; 10(16)2021 Aug 17.

Article en En | MEDLINE | ID: mdl-34441934

Palabras clave

Alzheimer's disease; Down syndrome; biomarkers; blood; cerebrospinal fluid; positron emission tomography

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google